SOD1 and polycystic ovary syndrome: A case-control study conducted by Enechukwu et al. on 50 PCOS patients revealed a significant decrease in the total antioxidant capacity (TAC) (p<o.oo1) and activity of SOD (p<0.001) when compared with 50 females with normal ovarian function [16].